The impact of SB1088 on state laws is minimal given its technical nature. By clarifying the title of the Epinephrine Injector Act, it ensures that the legislation is accurately referenced in legal contexts and is consistent with other related statutes. This could facilitate better understanding and compliance among those who must adhere to or implement the provisions of the Act, such as healthcare providers and emergency responders.
Summary
SB1088 is a bill introduced in the Illinois General Assembly aimed at amending the Epinephrine Injector Act. The primary focus of this bill is to implement a technical change in the Act, specifically regarding the short title of the legislation. The bill is a straightforward piece that does not introduce new regulations or substantive changes but seeks to refine the existing legal language for clarity. It is sponsored by Senator John F. Curran and was introduced on February 2, 2023.
Contention
There are no significant points of contention explicitly noted in the available discussions or voting records associated with SB1088. As a technical amendment, the bill is expected to garner broad support and is unlikely to face opposition. Its straightforward nature may also mean that it will progress through the legislative process with little debate.